Nicorette Invisi (Nicotine)

The nicotine in the patch acts as an agonist at nicotinic acetylcholine receptors in the brain. By providing a low, steady level of nicotine through the skin, it partially stimulates these receptors, which eases withdrawal symptoms while allowing the user to taper nicotine exposure over time.

The specific dose and duration of Nicorette Invisi are determined by the prescribing healthcare professional based on the individual’s smoking habits, nicotine dependence level, and medical history. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of nicotine patches during pregnancy or lactation has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and alternatives with their healthcare provider before using Nicorette Invisi.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nicorette Invisi provides a steady transdermal delivery of nicotine, which can be more convenient than oral forms such as gum or lozenges. Unlike prescription medications like varenicline, it does not act on dopamine pathways but simply replaces nicotine, offering a lower‑risk, over‑the‑counter alternative for many users.

Store the patches at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and heat sources. Do not expose the patches to extreme temperatures, as this can affect nicotine stability and patch adhesion.

The patch is applied to clean, dry, hair‑free skin on the upper arm, chest, or back. Press firmly for about 10 seconds to ensure good contact. Replace the patch with a new one according to the prescriber’s schedule, typically every 24 hours, and rotate application sites to avoid skin irritation.

Serious risks include severe allergic reactions such as swelling, hives, or rash, and cardiovascular events like chest pain or hypertension. Users should seek immediate medical attention if they experience any signs of an allergic reaction, severe skin irritation, dizziness, or chest discomfort while using the patch.

Nicorette Invisi should not be used by individuals with known hypersensitivity to nicotine or any patch components, by those with uncontrolled hypertension, recent heart attack, or serious cardiovascular disease, and by pregnant or breastfeeding women without medical advice. Children and adolescents should also avoid use unless specifically prescribed.